Medigene 관리
관리 기준 확인 4/4
Medigene's CEO is Selwyn Ho, appointed in Jul 2022, has a tenure of 2.33 years. total yearly compensation is €445.00K, comprised of 80.9% salary and 19.1% bonuses, including company stock and options. directly owns 0.42% of the company’s shares, worth €99.51K. The average tenure of the management team and the board of directors is 2 years and 7.3 years respectively.
주요 정보
Selwyn Ho
최고 경영자
€445.0k
총 보상
| CEO 급여 비율 | 80.9% |
| CEO 임기 | 2.3yrs |
| CEO 소유권 | 0.4% |
| 경영진 평균 재임 기간 | 2yrs |
| 이사회 평균 재임 기간 | 7.3yrs |
최근 관리 업데이트
This Is Why Shareholders May Want To Hold Back On A Pay Rise For Medigene AG's (ETR:MDG1) CEO
Jun 17
How Much Is Medigene's (ETR:MDG1) CEO Getting Paid?
Dec 23Recent updates
Here's Why We're Watching Medigene's (ETR:MDG1) Cash Burn Situation
Jan 03The Strong Earnings Posted By Medigene (ETR:MDG1) Are A Good Indication Of The Strength Of The Business
Aug 12Medigene AG (ETR:MDG1) Analysts Just Trimmed Their Revenue Forecasts By 41%
Aug 10We're Hopeful That Medigene (ETR:MDG1) Will Use Its Cash Wisely
Mar 24Here's Why We're Not Too Worried About Medigene's (ETR:MDG1) Cash Burn Situation
Nov 29This Is Why Shareholders May Want To Hold Back On A Pay Rise For Medigene AG's (ETR:MDG1) CEO
Jun 17We're Keeping An Eye On Medigene's (ETR:MDG1) Cash Burn Rate
Mar 29How Much Did Medigene's(ETR:MDG1) Shareholders Earn From Share Price Movements Over The Last Three Years?
Feb 16How Much Is Medigene's (ETR:MDG1) CEO Getting Paid?
Dec 23CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -€16m |
| Mar 31 2024 | n/a | n/a | -€16m |
| Dec 31 2023 | €445k | €360k | -€16m |
| Sep 30 2023 | n/a | n/a | -€23m |
| Jun 30 2023 | n/a | n/a | -€29m |
| Mar 31 2023 | n/a | n/a | -€19m |
| Dec 31 2022 | €612k | €157k | -€8m |
보상 대 시장: Selwyn's total compensation ($USD485.60K) is about average for companies of similar size in the German market ($USD488.36K).
보상과 수익: Selwyn's compensation has been consistent with company performance over the past year.
CEO
Selwyn Ho (53 yo)
2.3yrs
테뉴어
€445,000
보상
Dr. Selwyn Ho, MBBS, serves as Chief Executive Officer & Chairman of the Executive Management Board at Medigene AG since July 25, 2022. He served as Chief Business Officer at Connect Biopharma Holdings Lim...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| CEO & Chairman of Executive Management Board | 2.3yrs | €445.00k | 0.42% € 99.5k | |
| Chief Scientific Officer | 10.5yrs | €486.00k | 데이터 없음 | |
| Co-Founder & Chairman Scientific Advisory Board | no data | €20.00k | 데이터 없음 | |
| Chief Financial Officer | no data | 데이터 없음 | 데이터 없음 | |
| Vice President of Investor Relations & Corporate Communications | 1.7yrs | 데이터 없음 | 데이터 없음 | |
| VP and Head of Clinical Research & Development | 1.7yrs | 데이터 없음 | 데이터 없음 |
2.0yrs
평균 재임 기간
경험이 풍부한 관리: MDG1's management team is considered experienced (2 years average tenure).
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Co-Founder & Chairman Scientific Advisory Board | 7.3yrs | €20.00k | 데이터 없음 | |
| Independent Member of the Supervisory Board | 3.9yrs | €24.00k | 데이터 없음 | |
| Independent Deputy Chairwomen of the Supervisory Board | 8.3yrs | €38.00k | 데이터 없음 | |
| Independent Chairman of the Supervisory Board | 7.5yrs | €45.00k | 데이터 없음 | |
| Independent Member of the Supervisory Board | 7.5yrs | €26.00k | 데이터 없음 | |
| Independent Member of the Supervisory Board | 6.5yrs | €30.00k | 0.071% € 16.9k | |
| Member of Scientific Advisory Board | 7.3yrs | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | 7.3yrs | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | 7.3yrs | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | 7.3yrs | 데이터 없음 | 데이터 없음 | |
| Member of Scientific Advisory Board | 7.3yrs | 데이터 없음 | 데이터 없음 |
7.3yrs
평균 재임 기간
68yo
평균 연령
경험이 풍부한 이사회: MDG1's board of directors are considered experienced (7.3 years average tenure).